Long-term outcomes of narrow diameter implants in posterior jaws: A retrospective study with at least 8-year follow-up

Abstract Background: Aim of this retrospective study was to document the long-term clinical efficacy of a surgical-prosthetic technique (Flat-one-Bridge) involving immediate restoration of both post-extractive and non-post-extractive implants supporting full-arch restorations. Methods: Implants were placed adapting the axis to the available bone. Flat definitive abutments were connected at surgery and never disconnected in order to compensate for eventual implants dis-parallelism. Bone grafting was performed when needed. Patients received a screw-retained provisional restoration within 48 hours of surgery and a final screw-retained prosthesis within one year. Results: Sixty-six patients received 494 implants distributed in 75 prosthesis. The median follow-up was 86 months (range 82-168 months). Only three implants failed at the last follow-up. Implant survival was 99.6%. Conclusion: The Flat-one-Bridge prosthetic protocol is a viable procedure with excellent long-term outcomes. No difference could be observed between post-extractive and non post-extractive implants in terms of clinical success.

Download Full-text

P-BN25 Redo-Antireflux surgery long term quality of life retrospective study

British Journal of Surgery ◽

10.1093/bjs/znab430.025 ◽

2021 ◽

Vol 108 (Supplement_9) ◽

Author(s):

Hesham Mohamed ◽

Martin Kawabata ◽

Cicely Culmer ◽

Keerthanaa Veerapatherar ◽

Sanjoy Basu

Keyword(s):

Quality Of Life ◽

Retrospective Study ◽

Antireflux Surgery ◽

P Value ◽

Long Term Outcomes ◽

Before And After ◽

Related Quality

Abstract Background Gastro-oesophageal reflux disease (GORD) can have a significant effect on patients quality of life, especially in sever cases. Laparoscopic Antireflux surgery is the most common approach which offers promising long-term outcomes. However, Failure of antireflux procedures are reported in 5% to 10% of the patients who might require a redo-antireflux surgery (Redo-ARS). This study aims to assess the long-term outcomes of Redo-Antireflux surgeries regarding symptoms control and patient satisfaction. Methods Retrospective study for patients who underwent Redo-ARS with a single consultant in the south of England. Follow up was done using The GORD Health-Related Quality-of-Life (GORD-HRQL) scale and patients reported their scores before and after the redo-surgery. Exclusion criteria included follow up less than one year and failure of contacting the patient. Results All patients who underwent Redo-ARS between 2009-2019 were enlisted and 18 -out of the identified 22- were included in the study. Overall, There was a significant decrease in heartburn severity after the redo operation with a median reported severity of 4.5 preoperatively which decreased to 2 after the operation with a P value of 0.00062. This was observed in assessment of heartburn symptoms severity during sleep, laying flat, standing and after meals which all showed improvement after the operation with P values <0.005. There was no statistically significant improvement of dysphagia, odynophagia or bloating. The median follow up was 5 years. Conclusions Redo laparoscopic antireflux operations are technically challenging, however, significant heartburn symptoms control is feasible. Further evaluation of types of surgeries and patient selection can guide decisions regarding further management and guidelines.

Download Full-text

Outcomes and Complications of Sutured Scleral-Fixated Foldable Intraocular Lens Implantation: A Retrospective Study of 5-Year Follow-Up

Journal of Ophthalmology ◽

10.1155/2021/5525064 ◽

2021 ◽

Vol 2021 ◽

pp. 1-8

Author(s):

Ting Yu ◽

Mengting Yu ◽

Wenjie Wu ◽

Xinna Wu ◽

Suzhen Xiao ◽

...

Keyword(s):

Retrospective Study ◽

Intraocular Lens ◽

Tertiary Hospital ◽

Long Term Outcomes ◽

Iol Implantation ◽

Minimum Angle ◽

The Mean ◽

Iol Dislocation

Purpose. To evaluate long-term outcomes and complications of sutured scleral-fixated foldable intraocular lens (IOL) implantation. Design. Retrospective study. Methods. Patients who underwent sutured scleral-fixated foldable IOL implantation using 10-0 polypropylene suture were followed up for at least 5 years at one Chinese tertiary hospital and two primary hospitals. Results. 52 eyes among 48 patients (35 male and 13 female) were evaluated. The mean age (years) was 50.27 ± 20.08 (range: 6 to 81). The mean postoperative follow-up time (months) was 79.70 ± 18.84 (range: 60 to 121). The mean best-corrected visual acuity (BCVA) improved from 0.83 ± 0.69 logarithm of the minimum angle of resolution (logMAR) at baseline to 0.50 ± 0.45 logMAR at the last follow-up visit. There was improved or unchanged BCVA in 44 eyes (84.62%) and reduced BCVA in 8 eyes (15.38%). Mild intraoperative intravitreal hemorrhage was observed in 3 eyes (5.77%). Early postoperative complications included transient elevated intraocular pressure (IOP) in 5 eyes (9.62%) and hypotony in 1 eye (1.92%). Secondary epimacular membrane occurred in 5 eyes (9.62%) and retinal detachment (RD; 3 years postsurgery), subconjunctival suture knot exposure (5 years postsurgery), and persistent elevated IOP (in a GRAVES patient) occurred in 1 eye (1.92%) each. No suture erosion or breakage nor IOL dislocation was observed. No visually threatening IOL tilt or decentration was reported in any patient. Conclusion. Sutured scleral-fixated foldable IOL implantation demonstrated satisfactory long-term outcomes and rare suture-related complications. This technology was safe and did not require complicated equipment and is of considerable interest in the setting of aphakia without adequate capsule support.

Download Full-text

Immediate restoration of fixed full-arch prostheses placed on implants in both fresh and healed sockets using the flat one-bridge technique: a 7-year retrospective study

BMC Oral Health ◽

10.1186/s12903-021-01988-0 ◽

2021 ◽

Vol 21 (1) ◽

Author(s):

Simone Marconcini ◽

Enrica Giammarinaro ◽

Ugo Covani ◽

Andrea Mascolo ◽

Guerino Caso ◽

...

Keyword(s):

Retrospective Study ◽

Clinical Efficacy ◽

Bone Grafting ◽

Clinical Success ◽

Implant Survival ◽

Long Term Outcomes ◽

Provisional Restoration

Abstract Background The aim of this retrospective study was to document the long-term clinical efficacy of a surgical-prosthetic technique (the flat one-bridge technique) involving the immediate restoration of both postextraction and nonpostextraction implants supporting full-arch restorations. Methods Implants were placed by adapting the axis to the available bone. Flat definitive abutments were connected during surgery and never disconnected to compensate for eventual implant disparallelism. Bone grafting was performed when needed. The patients received a screw-retained provisional restoration within 48 h of surgery and a final screw-retained prosthesis within 1 year. Results Sixty-six patients received 494 implants distributed in 75 prostheses. The median follow-up was 86 months (range 82–168 months). Only three implants had failed at the last follow-up. Implant survival was 99.6%. Conclusion The flat one-bridge prosthetic protocol is a viable procedure with excellent long-term outcomes. No difference in clinical success could be observed between postextractive and nonpostextractive implants.

Download Full-text

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy

Frontiers in Oncology ◽

10.3389/fonc.2021.754108 ◽

2022 ◽

Vol 11 ◽

Author(s):

Gilda Cennamo ◽

Daniela Montorio ◽

Luca D’ Andrea ◽

Antonio Farella ◽

Elide Matano ◽

...

Keyword(s):

Retrospective Study ◽

Uveal Melanoma ◽

Tumor Control ◽

Long Term Outcomes ◽

Long Term Follow Up ◽

The Mean ◽

Lost To Follow Up ◽

Plaque Brachytherapy

Uveal melanoma is the most common primary intraocular malignancy. The aim of this retrospective study was to report the results after ruthenium-106 (Ru-106) plaque brachytherapy for uveal melanoma in terms of tumor control, visual acuity, radiation-related complications, tumor recurrence, metastases, and patients’ survival rate during 4 years’ follow-up. A total of 355 eyes from 355 patients have been treated with Ru-106 plaque brachytherapy for uveal melanoma between February 2011 and March 2020. Five patients were lost to follow-up, and then 350 eyes of 350 patients (mean age 58 ± 11 years) were enrolled in this retrospective study. All patients underwent a complete ophthalmic examination including echography and spectral domain–optical coherence tomography. The mean follow-up was 4 years (3 months to 9 years). After treatment, the mean tumor thickness was reduced to 1.75 ± 0.21 mm. Radiation complications were found in 63% of patients: 38% showed radiation maculopathy, 11% had optic neuropathy, and 14% developed cataracts. Cancer-free survival was 99%, 97%, and 85%, respectively, at 5, 7, and 9 years. Ru-106 plaque brachytherapy represents a reliable treatment of uveal melanoma. This technique is valid and safe with a low rate of ocular complications during a long-term follow-up.

Download Full-text

Short- and Long-term Outcomes of Medically Treated Isolated Left-Sided Endocarditis: A Retrospective Study With 5-Year Longitudinal Follow-up

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2019.10.039 ◽

2020 ◽

Vol 36 (9) ◽

pp. 1534-1540 ◽

Cited By ~ 1

Author(s):

Carmichael Mabilangan ◽

Holly Cole ◽

Brett Hiebert ◽

Yoav Keynan ◽

Rakesh C. Arora ◽

...

Keyword(s):

Retrospective Study ◽

Long Term Outcomes ◽

Short And Long Term

Download Full-text

Influence of implant protrusion length on non-grafting osteotome sinus floor elevation with simultaneous implant: a 3- to 9-year retrospective study

International Journal of Implant Dentistry ◽

10.1186/s40729-021-00304-3 ◽

2021 ◽

Vol 7 (1) ◽

Author(s):

Yi Yu ◽

Qiming Jiang ◽

Zhengchuan Zhang ◽

Xiaolin Yu ◽

Feilong Deng

Keyword(s):

Retrospective Study ◽

Long Term Outcomes ◽

Optimal Range ◽

Sinus Floor Elevation ◽

Cumulative Survival ◽

Implant Placement ◽

Sinus Floor ◽

Osteotome Sinus Floor Elevation

Abstract Background This study analyzed the influence of implant protrusion length (IPL) on the possible factors that affect the long-term outcomes utilizing non-grafting osteotome sinus floor elevation (OSFE) with simultaneous implant placement, and to explore the optimal range of IPL. Materials and methods A retrospective study design was adopted. The clinical and radiographic data of 105 implants in 65 patients were collected after 3–9 (mean 5.04) years follow-up. IPL was divided into three groups (group1, IPL<2mm; group2, 2mm≤IPL<4mm; group3, IPL≥4mm). Endo-sinus bone gain (ESBG), peri-implant marginal bone loss (MBL), bone to implant contact length (BICL), and percentage of ESBG (%ESBG) were used to evaluate non-grafting OSFE. A Kaplan-Meier analysis was performed to assess the cumulative survival rate. Multiple linear regression model was used to explore the relationship between the possible influence factors and ESBG. Analysis of variance (ANOVA) was applied to explore the correlation of IPL with ESBG, MBL, BICL, and %ESBG. Results A total of 102 implants in 62 patients fulfilled the survival criteria, giving the cumulative survival rates of 96.4% and 94.1% for implant-based analysis and patient-based analysis, respectively. The mean ESBG, MBL, and BICL at the latest follow-up were 1.95±0.88 mm, 0.58±0.68 mm, and 5.51±1.47 mm. ESBG was found to be positively correlated to IPL. A significant decreased bone formation efficiency was found when IPL was over 4 mm (P=0.02). Conclusions An optimal range of IPL within 4 mm was recommended for better long-term outcomes when applying non-grafting OSFE with simultaneous implant placement.

Download Full-text

Periprocedural risk and long-term outcome of intracranial angioplasty based on a single-centre experience

VASA ◽

10.1024/0301-1526/a000287 ◽

2013 ◽

Vol 42 (4) ◽

pp. 264-274

Author(s):

Dagmar Krajíčková ◽

Antonín Krajina ◽

Miroslav Lojík ◽

Martina Mulačová ◽

Martin Vališ

Keyword(s):

Death Rate ◽

Long Term Outcomes ◽

Single Centre ◽

Intracranial Atherosclerotic Stenosis ◽

Atherosclerotic Stenosis ◽

Angioplasty And Stenting ◽

Aggressive Medical Management ◽

Stroke Death

Background: Intracranial atherosclerotic stenosis is a major cause of stroke and yet there are currently no proven effective treatments for it. The SAMMPRIS trial, comparing aggressive medical management alone with aggressive medical management combined with intracranial angioplasty and stenting, was prematurely halted when an unexpectedly high rate of periprocedural events was found in the endovascular arm. The goal of our study is to report the immediate and long-term outcomes of patients with ≥ 70 % symptomatic intracranial atherosclerotic stenosis treated with balloon angioplasty and stent placement in a single centre. Patients and methods: This is a retrospective review of 37 consecutive patients with 42 procedures of ballon angioplasty and stenting for intracranial atherosclerotic stenosis (≥ 70 % stenosis) treated between 1999 and 2012. Technical success (residual stenosis ≤ 50 %), periprocedural success (no vascular complications within 72 hours), and long-term outcomes are reported. Results: Technical and periprocedural success was achieved in 90.5 % of patients. The within 72 hours periprocedural stroke/death rate was 7.1 % (4.8 % intracranial haemorrhage), and the 30-day stroke/death rate was 9.5 %. Thirty patients (81 %) had clinical follow-up at ≥ 6 months. During follow-up, 5 patients developed 6 ischemic events; 5 of them (17 %) were ipsilateral. The restenosis rate was 27 %, and the retreatment rate was 12 %. Conclusions: Our outcomes of the balloon angioplasty/stent placement for intracranial atherosclerotic stenosis are better than those in the SAMMPRIS study and compare favourably with those in large registries and observational studies.

Download Full-text